Substrate and inhibitor to CYP 2C9. Compare the other oxicams (probably not porphyrinogenic

(To be edited, initial data ST OCT 04) Solution for injection; 8-16 mg/d. Analgetic and antipyretic oxicam derivative for short-time use where peroral administration is unsuitable. Totally metabolized by hydroxylation (CYP 2C9). Inhibitor of CYP 2C9.